Meihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)

Simply Wall St.09-25

Meihua International Medical Technologies (NASDAQ:MHUA) First Half 2024 Results Key Financial Results Revenue: US$45.3m (down 5.9% from 1H 2023). Net income: US$4.72m (down 33% from 1H 2023). Profit ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470324230?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","is_english":true,"pubTime":"2024-09-25 18:27","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2470324230","market":"us","top_or_hot":-1,"title":"Meihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)","media":"Simply Wall St.","content":"<div>\n<p>Meihua International Medical Technologies (NASDAQ:MHUA) First Half 2024 Results\nKey Financial Results\n\nRevenue: US$45.3m (down 5.9% from 1H 2023).\nNet income: US$4.72m (down 33% from 1H 2023).\nProfit ...</p>\n\n<a href=\"https://finance.yahoo.com/news/meihua-international-medical-technologies-first-102720691.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeihua International Medical Technologies First Half 2024 Earnings: EPS: US$0.19 (vs US$0.29 in 1H 2023)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-25 18:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/meihua-international-medical-technologies-first-102720691.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meihua International Medical Technologies (NASDAQ:MHUA) First Half 2024 Results\nKey Financial Results\n\nRevenue: US$45.3m (down 5.9% from 1H 2023).\nNet income: US$4.72m (down 33% from 1H 2023).\nProfit ...</p>\n\n<a href=\"https://finance.yahoo.com/news/meihua-international-medical-technologies-first-102720691.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MHUA","symbol_name":"美华国际","start_time":0,"source_url":"https://finance.yahoo.com/news/meihua-international-medical-technologies-first-102720691.html","article_id":"2470324230","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470324230","pubTimestamp":1727260040,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Meihua International Medical Technologies  First Half 2024 Results. Profit margin: 10% . The decrease in margin was driven by lower revenue.NasdaqGM:MHUA Earnings and Revenue History September 25th 2024. All figures shown in the chart above are for the trailing 12 month  period. Meihua International Medical Technologies shares are down 9.0% from a week ago.It's necessary to consider the ever-present spectre of investment risk.   We've identified 4 warning signs  with Meihua International Medical Technologies , and understanding them should be part of your investment process.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MHUA":"美华国际"},"translate_title":"美华国际医疗科技2024年上半年收益：每股收益：美国0.19美元（2023年上半年美国0.29美元）","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MHUA":1},"content_text":"Meihua International Medical Technologies (NASDAQ:MHUA) First Half 2024 Results\nKey Financial Results\n\nRevenue: US$45.3m (down 5.9% from 1H 2023).\nNet income: US$4.72m (down 33% from 1H 2023).\nProfit margin: 10% (down from 15% in 1H 2023). The decrease in margin was driven by lower revenue.\nEPS: US$0.19 (down from US$0.29 in 1H 2023).\n\n\n\n\n  NasdaqGM:MHUA Earnings and Revenue History September 25th 2024\n \n\nAll figures shown in the chart above are for the trailing 12 month (TTM) period\n Meihua International Medical Technologies shares are down 9.0% from a week ago. \nRisk Analysis\n It's necessary to consider the ever-present spectre of investment risk.   We've identified 4 warning signs  with Meihua International Medical Technologies (at least 2 which are concerning), and understanding them should be part of your investment process. \nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470324230"}